Milestone Pharmaceuticals Inc.

Taimed Biologics, Inc.

Taimed Biologies, Inc.

Dominik Herbart

Brent Richard Stranix

Jean-Francois Lavallee

Guy Milot

Nicolas Leberre

Chandra Panchal

Harry Jefferson Leighton

Martin P Maguire

Harry J Leighton

Chandra J Panchal

The present invention provides HIV protease inhibitors of formulas I, IA, IB, Ib or II, or pharmaceutically acceptable salts thereof, wherein Rmay be, for example, 2-pyridyl-CH&#x2014;, 3-pyridyl-CH&#x2014;, 4-pyridyl-CH&#x2014;, a sulfonyl group as described in the formulas herein including benzenesulfonyl or thiophenesulfonyl groups, R&#x2014;CO)&#x2014;, Rbeing selected from the group consisting of piperonyl, 2-pyranzinyl (unsubstituted or substituted with H, or an alkyl of 1 to 4 carbon atoms) or a picolylamine group as described herein, wherein R3 may be, for example, a phenyl group or diphenylmethyl group as described herein, and wherein Cx may be, for example, COOH, CONRR, CHOH or CHOR.

Protease inhibitors

The present invention relates to short-acting calcium channel blocking compounds and their use to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension in general, hypertension been.) fore, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow. The invention also relates to pharmaceutical compositions formulated for use in such methods and to kits for such methods.

Short acting benzothiazepine calcium channel blockers and uses thereof

The present invention provides HIV protease inhibitors of formulas I, IA, IB, Ib or II, or pharmaceutically acceptable salts thereof, wherein Rmay be, for example, 2-pyridyl-CH&#x2014;, 3 -pyridyl-CH&#x2014;, 4-pyridyl-CH&#x2014;, a sulfonyl group as described in the formulas herein including benzenesulfonyl or thiophenesulfonyl groups, R&#x2014;CO&#x2014;, Rbeing selected from the group consisting of piperonyl, 2-pyrazinyl (unsubstituted or substituted with H, or an alkyl of 1 to 4 carbon atoms) or a picolylamine group as described herein, wherein R3 may be, for example, a phenyl group or diphenylmethyl group as described herein, and wherein Cx may be, for example, COOH, CONRR, CHOH or CHOR.

Growing community of inventors

Blainville, Canada

Dominik Herbart